approved

NKGen Biotech Advances Alzheimer’s Treatment with SNK01: First Patient Dosed in Phase 1/2a Trial

December 29, 2023 - NKGen Biotech, Inc. (Nasdaq: NKGN) is making strides in Alzheimer's disease (AD) treatment with the dosing of the first patient in its Phase 1/2a trial for SNK01, an autologous natural killer (NK) cell therapy. The innovative product, designed for moderate AD, has demonstrated promising results in neuroinflammation and cognitive function during its Phase 1 safety trial. Key Points: SNK01 Efficacy: NKGen's SNK01, a cryopreserved autologous NK cell therapy, showed improvement in neuroinflammation and cognitive function in the Phase 1 dose-escalation safety trial. The therapy boasts enhanced

Walking the Tightrope

As we stand on the verge of a new era in crypto, it’s crucial to reaffirm the importance of decentralization. Beyond being a mere aspiration, decentralization serves as the lifeblood of the crypto world, standing as the pivotal force that draws the line between freedom and control. Amidst the hype surrounding the impending approval of a spot Bitcoin ETF in the United States, accompanied by the influx of capital from behemoths like BlackRock, the immediate market surge raises a serious question for the future of crypto. Are people here for

Clockout Breaks New Ground in Wage Access. Launches and Expands its Reach to 42 States

Historically, on-demand wage access required significant backend adjustments, coordination and often posed integration hurdles for employers. Clockout, a cutting-edge fintech platform, is pushing the boundaries of the traditional earned wage access model. In a bold move to address common industry challenges, the company has unveiled a streamlined, implementation-free model for employers, eliminating the need for cumbersome contracts and implementations and making offering their workforce immediate access to earned wages effortless. Clockout amplifies businesses' employee motivation, retention, and hiring leverage; while placing the power directly in the hands of the employees

CoinSmart Announces Acquisition by Coinsquare, Creating one of Canada’s Largest Crypto Asset Trading Platforms

TORONTO, Sept. 22, 2022 /CNW/ - CoinSmart Financial Inc. ("CoinSmart" or the "Company") (NEO: SMRT) (FSE: IIR), announced today that it has entered into a definitive agreement dated September 22, 2022 (the "Purchase Agreement") with Coinsquare Ltd. ("Coinsquare"), a leading Canadian crypto asset trading platform, pursuant to which CoinSmart has agreed to sell to Coinsquare all of the issued and outstanding shares of its wholly-owned operating subsidiary Simply Digital Technologies Inc. ("Simply Digital") (the "Transaction"). The acquisition and integration of these two businesses will establish Coinsquare as one of Canada's

Spirit Blockchain Capital Inc. Announces setting up its first Avalanche Validator Node.

VANCOUVER, British Columbia, September 06, 2022 (GLOBE NEWSWIRE) -- Spirit Blockchain Capital Inc. (the “Company” or “Spirit”), a Canadian company that offers shareholders diversified exposure to the Blockchain and crypto industry, is pleased to announce that it has made an investment in AVAX and has setup its own validator node to help secure the Avalanche network. Avalanche is one of the world’s most decentralized high-performance blockchains and continues to experience rapid growth. The Avalanche network is a Proof-of-Stake (PoS) smart contract platform that is focused on scalability and offers fast